20 reports

PYLORI ## Lab Tests ## Costs ## TABLE ## GASTROINTESTINAL ENDOSCOPY EXAMINATIONS IN U. S., 2009 (MILLIONS) ## SERUM PEPSINOGEN PREDICTS GASTRIC ADENOCARCINOMA ## CHAPTER ## GASTRIC CANCER TREATMENT OPTIONS ## CURRENT PRACTICES ## TABLE ## TYPES OF STANDARD TREATMENT ## CHEMOPREVENTION ## ANTI

  • Cancer
  • Gastric Cancer
  • Pathology
  • World
  • Market Size
  • Other cancers
  • Disease overview
  • Gastric Cancer
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • SYMPTOMS OF GASTRIC CANCER
  • 3.1.1 Etiology

ITALIAN GASTROINTESTINAL TUMOR STUDY GROUP.

  • Gastric Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • Gastric Cancer Therapeutics Market, South Korea, Treatment Patterns ('000), 2015-2022
  • Gastric Cancer Therapeutics Market, China, Treatment Patterns ('000), 2015-2022

Gastrointestinal Endoscopy; ##(##): ##-## Chung HC, et al. (2016).

  • Gastric Cancer
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group

Gastric cancer

4546 5000 3864
  • Opdivo patient numbers for gastric cancer in Japan, 2015-24
  • GASTRIC CANCER HAS HIGH GLOBAL INCIDENCE AND MORTALITY RATES

Gastrointestinal Cancer Research, ##(##), ##-## < PMID> ##< / PMID>.

  • Gastric Cancer
  • Asia
  • Japan
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • 3.1 DISEASE BACKGROUND
  • 3.4.1 Sources Used

Researchers of the prospective study obtained data on patients with GEJ cancer among all upper gastrointestinal tract cancer from the database established by the Kanagawa Cancer Center.

  • Gastric Cancer
  • China
  • Japan
  • World
  • Forecast
  • SYMPTOMS OF GASTRIC CANCER
  • 3.1.1 Etiology

ITALIAN GASTROINTESTINAL TUMOR STUDY GROUP.

  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • SYMPTOMS OF GASTRIC CANCER
  • 3.1.1 Etiology

ITALIAN GASTROINTESTINAL TUMOR STUDY GROUP.

  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • SYMPTOMS OF GASTRIC CANCER
  • 3.1.1 Etiology

ITALIAN GASTROINTESTINAL TUMOR STUDY GROUP.

  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • SYMPTOMS OF GASTRIC CANCER
  • 3.1.1 Etiology

ITALIAN GASTROINTESTINAL TUMOR STUDY GROUP.

  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • Products under Development by Companies, H2 2017

Pts on BOS had significantly higher rates of ##-mo MMR and CCyR and achieved responses faster than those on IM, and had higher incidence of gastrointestinal events and transaminase elevations.

  • Gastric Cancer
  • Targeted Therapy
  • Therapy
  • Product Initiative
  • Pfizer Inc.
  • 04/20/2017: Five Prime to Present Clinical Data on FPA144 at 2017 ASCO Annual Meeting

Charles Fuchs, Director of the Center for Gastrointestinal Cancer, Dana Farber Cancer Institute.

  • Gastric Cancer
  • Pharmaceutical
  • United States
  • Company
  • Five Prime Therapeutics, Inc.
  • Official Title
  • Clinical Trial profile. 1421 Trial Title

To date, the program includes four gastric cancer registrationenabling studies and numerous other gastrointestinal cancer studies are underway.

  • Chemotherapy
  • Clinical Trial
  • Gastric Cancer
  • Therapy
  • World
  • Clinical Trial profile. 66 Trial Title
  • 5. All the trials included are unique trials.

Gastrointestinal Cancers, Treated with First-line Chemotherapy: A Randomized Phase III Trial Early Palliative Care in Patients with Metastatic Upper Gastrointestinal Cancers Treated with First-line Chemotherapy GDCT## NCT##, EudraCT-2015-A##-##; 2015-A##-##; EPIC-##

  • Clinical Trial
  • Gastric Cancer
  • Lung Cancer
  • World
  • Product Initiative
  • Clinical Trial profile. 1141 Trial Title
  • Clinical Trial profile. 1305 Trial Title

Platinum for Gastrointestinal Peritoneal Carcinomatosis Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I. P.

  • Clinical Trial
  • Gastric Cancer
  • Therapy
  • World
  • F. Hoffmann-La Roche Ltd.
  • DIFFERENT TYPES OF GASTRIC CANCER

Lymphoma: It is a cancer of the immune system tissue that is occasionally found in the Gastrointestinal Stromal Tumor (GIST): It is a rare tumor that starts in very early forms of cells in the wall of the stomach.

  • Gastric Cancer
  • United States
  • World
  • Market Size
  • Merck & Co., Inc.
  • Apr 21, 2016: Imugene submits regulatory package for HER-Vaxx Phase 1b/2 study in gastric cancer

For our Hong Kong site, Imugene is pleased to announce that the Principal Investigator will be Dr Thomas Yau, one of Hong Kong' s leading medical oncologists, whose main research priority is gastrointestinal oncology.

  • Gastric Cancer
  • Australia
  • Company
  • M&A
  • Imugene Limited
  • MGD-007 - DRUG PROFILE
  • CGX-1321 - DRUG PROFILE

AS OF FEBRUARY 2013, IT WAS IN PHASE II FOR GASTROINTESTINAL STROMAL TUMOR (GIST).

  • Gastric Cancer
  • Monoclonal Antibody
  • North America
  • United States
  • Product Initiative
  • GASTRIC CANCER - PIPELINE BY EDDINGPHARM INC
  • GASTRIC CANCER - PIPELINE BY GLYCONEX INC

ITS PIPELINE CANDIDATES ARE USED TO TREAT THE GASTROINTESTINAL AND CRC AND ORPHAN DISEASES.

  • Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Pharmaceutical
  • Merck & Co., Inc.
  • Gastric Cancer, Programs Targeting FGFR 3
  • Gastric Cancer, Heatmap for First-Line Marketed Products

Gastrointestinal toxicities included nausea, vomiting, and diarrhea.

  • Cancer
  • Gastric Cancer
  • Pathology
  • Therapy